1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Does Higher Compliance With American College of Sports Medicine Exercise Prescription Guidelines Influence Exercise Outcomes in Knee Osteoarthritis? A Systematic Review With Meta-Analysis
2024) In Arthritis Care and Research(
- Contribution to journal › Scientific review
-
Mark
Diagnostic Accuracy of Candidate Magnetic Resonance Imaging Knee Osteoarthritis Definitions Versus Radiograph in an Acute Anterior Cruciate Ligament Injury Cohort
(
- Contribution to journal › Article
-
Mark
Evaluating Criteria for Symptoms Suggestive of Early Osteoarthritis Over Two Years Post–Anterior Cruciate Ligament Reconstruction : Data From the New Zealand Anterior Cruciate Ligament Registry
2024) In Arthritis Care and Research(
- Contribution to journal › Article
- 2023
-
Mark
Association of Traumatic Knee Injury With Radiographic Evidence of Knee Osteoarthritis in Military Officers
(
- Contribution to journal › Article
-
Mark
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling
(
- Contribution to journal › Article
- 2022
-
Mark
Socioeconomic inequalities in all‐cause and cause‐specific mortality among patients with osteoarthritis in the Skåne region, Sweden
(
- Contribution to journal › Article
-
Mark
Exploring the Associations Among Occupational Balance and Health of Adults With and Without Inflammatory Arthritis
(
- Contribution to journal › Article
-
Mark
Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index
(
- Contribution to journal › Article
-
Mark
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis : Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
(
- Contribution to journal › Article
-
Mark
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
(
- Contribution to journal › Article